Assessment of the Development of New Regional Dermatoses in Patients Treated for Atopic Dermatitis With Dupilumab.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 31042259.
- Also identified by DOI 10.1001/jamadermatol.2019.0109 and PMC identifier 6495362.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This cohort study describes the epidemiology, clinical features, and treatment of patients with moderate-to-severe atopic dermatitis and the association of developing new regional dermatoses with dupilumab treatment.
Medical subject headings
- Antibodies, Monoclonal, Humanized
- Dermatitis, Atopic
- Skin Diseases